Form SCHEDULE 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P. Mar 17, 2026 04:36PM
Acumen Pharmaceuticals raises $35.75 million in private placement Mar 16, 2026 06:30AM
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio Mar 16, 2026 06:30AM
Form SCHEDULE 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P. Mar 31, 2025 04:57PM
Form SC 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P. Jul 25, 2023 04:32PM


Nov 14, 2022 04:01PM Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
Nov 14, 2022 04:01PM Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
Sep 13, 2021 04:31PM Form SC 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 16, 2021 04:31PM Form SC 13D Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.